Stem cells

Stem cells

Spec 7.3 · Edexcel A-Level Biology B: Revision notes

Studying this course? Keep your progress in one place.

Key facts

  • A stem cell divides by mitosis and can differentiate; potency is the range of cell types it can form.
  • Totipotent cells form every cell type including the placenta; pluripotent cells form every body cell type but not the placenta; multipotent cells form a limited range.
  • Potency is lost by epigenetic modification and transcription factors, not by losing genes.
  • iPS cells are made by reprogramming differentiated cells and avoid destroying embryos or rejection.

What is a stem cell?

A stem cell is undifferentiated, can renew itself by mitosis and can differentiate; its potency is the range of cells it can form.

A stem cell is an undifferentiated cell that can divide by mitosis to make more stem cells (self-renewal) and can differentiate into specialised cells.

Stem cells are classified by their potency, the range of cell types they can form.

  • Totipotent: every cell type, including extra-embryonic tissue such as the placenta (zygote, very early embryo).
  • Pluripotent: every cell type of the body but not the placenta (inner cell mass of the blastocyst).
  • Multipotent: a limited range of related cell types (e.g. haematopoietic stem cells in bone marrow).
  1. 1

    Zygote: totipotent

    every cell type, including the placenta

  2. 2

    Inner cell mass: pluripotent

    every body cell type, not the placenta

  3. 3

    Adult stem cell: multipotent

    a limited range of related cells, e.g. bone marrow

  4. 4

    Specialised cell

    differentiated

Potency falls as cells specialise.

Totipotent

Can form:
Every cell type, including the placenta
Found in:
Zygote and very early embryo

Pluripotent

Can form:
Every body cell type, not the placenta
Found in:
Inner cell mass of the blastocyst

Multipotent

Can form:
A limited range of related cell types
Found in:
e.g. bone marrow

Which cells can form every cell type including the placenta?

From zygote to differentiated cell

Every cell has the same genome; epigenetic modification and transcription factors silence genes, narrowing potency.

Every cell has the same genome, so loss of potency during development is caused by epigenetic modification and the action of transcription factors, not by loss of genes. The pattern of modification is passed on by mitosis.

In the pluripotent inner cell mass of the blastocyst, modifications such as DNA methylation, histone modification and non-coding RNA silence genes such as those for placental tissue. Further modification restricts cells to fewer types, until a differentiated cell expresses only the genes for one function.

  1. 1

    Totipotent embryo cells

    develop into a blastocyst

  2. 2

    Pluripotent inner cell mass

    epigenetic modifications silence genes for placental tissue

  3. 3

    Multipotent cells

    further modification restricts cells to a smaller range

  4. 4

    Differentiated somatic cell

    expresses only the genes for one function

Loss of potency during development

Why does a differentiated cell lose potency?

Embryonic stem cells in medicine

Embryonic stem cells could replace damaged cells, but obtaining them destroys an embryo, raising ethical issues.

Pluripotent stem cells from embryos (usually spare IVF embryos at the blastocyst stage) can be grown and directed to form many cell types.

They offer new medical advances, for example replacement cells for spinal cord injury, diabetes (beta cells), heart disease or blindness, and models for testing drugs.

Examiners expect you to weigh both sides of an ethical consideration, not list only one.

  1. 1

    Spare IVF embryo

    grown to the blastocyst stage

  2. 2

    Inner cell mass removed

    this destroys the embryo

  3. 3

    Pluripotent cells cultured

    and directed to differentiate

  4. 4

    Replacement cells

    for example beta cells or spinal cord cells

Using embryonic stem cells in medicine.

Arguments for

  • Spare IVF embryos would be discarded anyway
  • The embryo is at a very early stage
  • The benefit to patients is great

Arguments against

  • Obtaining the cells destroys the embryo, a potential human life
  • The embryo cannot give consent
  • Cells differ genetically from the patient: risk of rejection

Which is an argument for using spare IVF embryos?

Induced pluripotent stem cells

iPS cells are made by reprogramming a differentiated cell with named genes, avoiding the destruction of embryos.

iPS cells are made by reprogramming a differentiated cell. Fibroblasts (connective tissue cells, easily taken from skin) are given named genes, such as Oct4, Sox2, Klf4 and c-Myc, often using a virus as a vector.

These genes code for transcription factors that switch on pluripotency genes and reverse the epigenetic modifications that had silenced them.

The cells are genetically identical to the patient, so there is less risk of rejection. Risks: c-Myc can cause cancer, viral vectors may disrupt other genes, and leftover undifferentiated cells can form tumours.

  1. 1

    Take fibroblasts

    easily taken from the patient's skin

  2. 2

    Add Oct4, Sox2, Klf4 and c-Myc

    often using a virus as a vector

  3. 3

    Reprogrammed iPS cells

    pluripotent; no embryo destroyed

  4. 4

    Differentiate

    genetically identical to the patient, but with a tumour risk

Making induced pluripotent stem cells.

Embryonic stem cells

Issue:
Destroys an embryo
Consequence:
Genetically different from patient: rejection risk

iPS cells

Issue:
No embryo destroyed
Consequence:
Genetically identical to patient; tumour risk

What is used to make a fibroblast pluripotent?

Try an exam question

Explain why induced pluripotent stem (iPS) cells may be preferred to embryonic stem cells for treating a patient.

[4 marks]

That's the notes covered.

Carry on to the next subtopic.

Try a question

Which term describes the haematopoietic stem cells in the bone marrow?

1 mark, marked against the mark scheme

Revision notes